TY - JOUR
T1 - Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.
AU - Hambardzumyan, Karen
AU - Bolce, Rebecca J
AU - Saevarsdottir, Saedis
AU - Forslind, Kristina
AU - KARLSSON WALLMAN, JOHAN
AU - Cruickshank, Scott E
AU - Sasso, Eric H
AU - Chernoff, David
AU - van Vollenhoven, Ronald F
PY - 2016
Y1 - 2016
N2 - In rheumatoid arthritis (RA), predictive biomarkers for subsequent radiographic progression (RP) could improve therapeutic choices for individual patients. We previously showed that the multibiomarker disease activity (MBDA) score in patients with newly diagnosed RA identified patients at risk for RP. We evaluated the MBDA score at multiple time-points as a predictor of RP during 2 years of follow-up.
AB - In rheumatoid arthritis (RA), predictive biomarkers for subsequent radiographic progression (RP) could improve therapeutic choices for individual patients. We previously showed that the multibiomarker disease activity (MBDA) score in patients with newly diagnosed RA identified patients at risk for RP. We evaluated the MBDA score at multiple time-points as a predictor of RP during 2 years of follow-up.
U2 - 10.1136/rmdopen-2015-000197
DO - 10.1136/rmdopen-2015-000197
M3 - Article
C2 - 26958364
SN - 2056-5933
VL - 2
SP - e000197
JO - RMD Open
JF - RMD Open
IS - 1
ER -